Maxheal Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 04-12-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 33.68 Cr
as on 04-12-2024
- Satisfied Charges ₹ 91.87 Cr
as on 04-12-2024
- Revenue 9.18%
(FY 2022)
- Profit 952.04%
(FY 2022)
- Ebitda 29.75%
(FY 2022)
- Net Worth 8.10%
(FY 2022)
- Total Assets -3.95%
(FY 2022)
About Maxheal Pharmaceuticals (India)
The Corporate was formerly known as Maxheal Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹33.68 Cr. The company has closed loans amounting to ₹91.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madanlal Sakhala, Hemlata Sakhala, Mehul Sakhala, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100MH2009PLC193624
- Company No.
193624
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Maxheal Pharmaceuticals (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Sakhala  | Managing Director | 29-Jun-2009 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madanlal Sakhala | Director | 01-Jul-2012 | Current |
| Hemlata Sakhala | Director | 29-Jun-2009 | Current |
| Pranita Sakhala | Director | 01-Jul-2017 | Current |
Financial Performance of Maxheal Pharmaceuticals (India).
Maxheal Pharmaceuticals (India) Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.18% increase. The company also saw a substantial improvement in profitability, with a 952.04% increase in profit. The company's net worth moved up by a moderate rise of 8.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxheal Pharmaceuticals (India)?
In 2022, Maxheal Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maxheal Laboratories Private LimitedActive 20 years 19 daysMadanlal Sakhala, Hemlata Sakhala and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 13 Jul 2010 | ₹33.68 Cr | Open |
Others Creation Date: 18 Jan 2021 | ₹2.56 Cr | Satisfied |
Others Creation Date: 26 May 2020 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Maxheal Pharmaceuticals (India)?
Maxheal Pharmaceuticals (India) has a workforce of 136 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxheal Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxheal Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
